Efficacy of liraglutide in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials
Open Access
- 7 April 2022
- journal article
- research article
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 22 (1) , 1-12
Abstract
Background: The efficacy of liraglutide to treat type 2 diabetic nephropathy (T2DN) remains controversial. Thus, we conducted this meta-analysis to systematically evaluate the clinical effect of liraglutide on T2DN patients. Methods: Eight databases (PubMed, Web of Science, the Cochrane Library, EMBASE, Chinese National Knowledge Infrastructure (CNKI), Wanfang database, China Science and Technology Journal Database, and China Biology Medicine Database (CBM)) were searched for published articles to evaluate the clinical efficacy of liraglutide in subjects with T2DN. The Revman 5.3 and Stata 13 software were used for analyses and plotting. Results: A total of 18 randomized controlled trials (RCTs) with 1580 diabetic nephropathy patients were screened. We found that the levels of UACR, Scr, Cysc were lower in the experimental group of T2DN patients treated with liraglutide than in the control group intervened without liraglutide. Liraglutide also reduced the levels of blood glucose (including FBG, PBG, and HbA1c), body mass index (BMI), and anti-inflammatory indicators (TNF–α, IL-6). However, there was no significant difference in BUN and eGFR between the experimental group and the control group. Conclusions: Liraglutide reduced the levels of Blood Glucose, BMI, renal outcome indicators, and serum inflammatory factors of patients with T2DN, suggesting the beneficial effects of liraglutide on renal function.Keywords
All Related Versions
This publication has 21 references indexed in Scilit:
- Signaling pathways in diabetic nephropathy2016
- Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine, 2016
- Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical TrialDiabetes Care, 2015
- Diabetic nephropathy: diagnosis and treatmentNature Reviews Endocrinology, 2013
- Meta-Analysis and SubgroupsPrevention Science, 2013
- Biology of Incretins: GLP-1 and GIPGastroenterology, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchangerNature Genetics, 1998
- Bias in meta-analysis detected by a simple, graphical testBMJ, 1997
- Statistical Aspects of the Analysis of Data From Retrospective Studies of DiseaseJNCI: Journal of the National Cancer Institute, 1959